CTMX vs HRL · rev $11.7M vs P/E 29, rev $8.96B
CytomX Therapeutics Inc (CTMX) versus Hormel Foods Corporation (HRL) — a side-by-side from cached financials, not a winner call.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
Hormel Foods Corporation (HRL) is a packaged foods company listed on NYSE.
Latest reported CTMX revenue for 2026-06-30 was $11.7M. Net income was -$38.9M. Revenue was up 13.8% from 2026-03-31 to 2026-06-30. CTMX currently screens at market cap $653.1M.
Latest reported HRL revenue for 2026-07-26 was $8.96B. Net income was $398.8M. Revenue was up 49.4% from 2026-04-26 to 2026-07-26. HRL currently screens at market cap $13.39B and trailing P/E 28.6.
CTMX currently screens at market cap $653.1M. HRL currently screens at market cap $13.39B and trailing P/E 28.6.
Not investment advice. Open the CTMX and HRL stock pages for the full models.
Not investment advice.